Showing results (781-790 of 795) with videos related to

Sort By:
Pageof 80
Science (New York, N.Y.)|December 11, 2013
In situ radiometric and exposure age dating of the martian surfaceK A Farley, C Malespin, P Mahaffy, et al.
The Journal of Small Animal Practice|November 18, 2021
Serum anti-GM2 and anti-GalNAc-GD1a IgG antibodies are biomarkers for acute canine polyradiculoneuritisS K Halstead, D S Gourlay, J Penderis, et al.
Psychological Medicine|May 2, 2023
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control studyEdoardo Spinazzola, Diego Quattrone, Victoria Rodriguez, et al.
Psychological Medicine|March 19, 2020
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control studyDiego Quattrone, Laura Ferraro, Giada Tripoli, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Consortium Profile: The Methylation, Imaging and NeuroDevelopment (MIND) ConsortiumIsabel K Schuurmans, Rosa H Mulder, Vilte Baltramonaityte, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 25, 2026
The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensusJoseph F Goldberg, Holly A Swartz, Roger S McIntyre, et al.
JAMA Network Open|February 25, 2026
Recommendations for the Deprescribing of Psychotropic Medications: A Consensus Statement From the American Society of Clinical Psychopharmacology Task ForceJoseph F Goldberg, Roger S McIntyre, Holly A Swartz, et al.
Translational Psychiatry|August 11, 2021
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI studyDiego Quattrone, Ulrich Reininghaus, Alex L Richards, et al.
Molecular Psychiatry|September 6, 2025
Consortium profile: the methylation, imaging and NeuroDevelopment (MIND) consortiumIsabel K Schuurmans, Rosa H Mulder, Vilte Baltramonaityte, et al.
Molecular Psychiatry|October 15, 2024
Methylomic signature of current cannabis use in two first-episode psychosis cohortsEmma L Dempster, Chloe C Y Wong, Joe Burrage, et al.
Pageof 80